MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature Ritse M. MannYvonne L. HoogeveenCarla Boetes Review Open access 15 February 2007 Pages: 1 - 14
TGFβ2 and TβRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells Miriam B. BuckJanet K. CollerCornelius Knabbe Preclinical Study 15 February 2007 Pages: 15 - 24
Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy Birendranath BanerjeeSanjiv SharmaM. Prakash Hande Preclinical Study 28 February 2007 Pages: 25 - 31
Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells John Yoonkeun JunJames W. GriffithAndrea Manni Preclinical Study 27 February 2007 Pages: 33 - 40
Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer Petra van der GroepMichael HoelzelPaul J. van Diest Preclinical Study Open access 27 February 2007 Pages: 41 - 47
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation Fabrice JourneGuy LaurentJean-Jacques Body Preclinical Study 28 February 2007 Pages: 49 - 61
Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of α-difluoromethylornithine in breast cancer cells Haifang XuSharlene WashingtonAndrea Manni Preclinical Study 27 February 2007 Pages: 63 - 70
Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen Mahmoud R. KhoshnoudTommy FornanderLars-Erik Rutqvist Clinical Trial 15 February 2007 Pages: 71 - 78
Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Karin LeunenMaria DrijkoningenIgnace Vergote Clinical Trial 13 April 2007 Pages: 79 - 86
Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03) Hiroyuki TakeiKimito SuemasuToshio Tabei Clinical Trial 15 February 2007 Pages: 87 - 94
Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1 Cheng-Ping YuJyh-Cherng YuAmy Ming-Fang Yen Epidemiology 15 February 2007 Pages: 95 - 102
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study Agnès FournierFranco BerrinoFrançoise Clavel-Chapelon Epidemiology 27 February 2007 Pages: 103 - 111
Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status Jolanta LissowskaMia M. GaudetMontserrat Garcia-Closas Epidemiology 21 February 2007 Pages: 113 - 117
BARD1 and breast cancer in Poland Anna JakubowskaCezary CybulskiJan Lubiński Epidemiology 27 February 2007 Pages: 119 - 122
Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study Asha R. KallianpurSang-Ah LeeWei Zheng Epidemiology 13 March 2007 Pages: 123 - 132
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer Rakhi P. NaikDavid JinLinda T. Vahdat Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary 15 February 2007 Pages: 133 - 138
Screening for ATM sequence alterations in African-American women diagnosed with breast cancer Ariel E. HirschDavid P. AtencioBarry S. Rosenstein Preclinical Study/Clinical Trial/Epidmiology/Invited Commentary 27 February 2007 Pages: 139 - 144
Quantitative detection of circulating epithelial cells by Q-RT-PCR Vladimir V. IakovlevRashmi S. GoswamiSusan J. Done Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary 09 March 2007 Pages: 145 - 154
No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers Muhammad U. RashidDiana TorresUte Hamann Letter to the Editor 15 February 2007 Pages: 155 - 156